ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Latest Form 4:Sale$174KbyOLUKOTUN ADEOYE Y (Director) · filed Aug 20, 2026
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) has 33 SEC Form 4 filings (91 transaction rows) in the rolling window, disclosed by 10 distinct insiders. Most recent filing: Aug 20, 2026.
The most active filer is Chief Executive Officer Anzalone Christopher Richard with 7 filings. Insiders have net sold $3.7M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Christopher R. Anzalone
- Employees:609
- HQ:Pasadena, CA, US
- IPO:1993-12-16
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$38.9M
reported sales (SEC code S)
Unique Insiders
10
in the rolling window
Market Cap
$12.0B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
OLUKOTUN ADEOYE YFirst in 8 months | Director | Sale | 2,000 | $174K | Aug 20 | SEC ↗ |
PERRY MICHAEL SFirst in 8 months | Director | Sale | 11,600 | $1.0M | Aug 20 | SEC ↗ |
| Director | Sale | 2,970 | $228K | May 14 | SEC ↗ | |
Apel Daniel JosephFirst filing | Chief Financial Officer | Sale | 13,095 | $934K | Apr 24 | SEC ↗ |
| Chief Medical Officer | Sale | 10,000 | $750K | Apr 24 | SEC ↗ | |
| Chief Medical Officer | Sale | 10,000 | $642K | Mar 9 | SEC ↗ | |
O'Brien PatrickFirst filing | COO | Sale | 49,493 | $3.1M | Jan 5 | SEC ↗ |
Hamilton James CFirst in 3 months | Chief Medical Officer | Sale | 40,164 | $2.5M | Jan 5 | SEC ↗ |
| Chief Executive Officer | Sale | 13,187 | $872K | Jan 5 | SEC ↗ | |
| Chief Executive Officer | Sale | 51,726 | $3.6M | Dec 30 | SEC ↗ | |
| Director | Sale | 7,530 | $527K | Dec 30 | SEC ↗ | |
| Chief Executive Officer | Sale | 13,445 | $910K | Dec 23 | SEC ↗ | |
| Chief Executive Officer | Sale | 12,586 | $861K | Dec 23 | SEC ↗ | |
Vakiener VictoriaFirst filing | Director | Sale | 10,040 | $679K | Dec 23 | SEC ↗ |
| Director | Sale | 8,367 | $566K | Dec 23 | SEC ↗ | |
OLUKOTUN ADEOYE YFirst filing | Director | Sale | 10,000 | $677K | Dec 23 | SEC ↗ |
| Chief Executive Officer | Sale | 85,000 | $5.4M | Dec 19 | SEC ↗ | |
Anzalone Christopher RichardFirst filing | Chief Executive Officer | Sale | 130,000 | $9.0M | Dec 16 | SEC ↗ |
Anzalone Christopher RichardFirst filing | Chief Executive Officer | Sale | 54,298 | $3.4M | Dec 16 | SEC ↗ |
PERRY MICHAEL SFirst filing | Director | Sale | 16,250 | $992K | Dec 9 | SEC ↗ |
Ferrari MauroFirst filing | Director | Sale | 8,750 | $493K | Dec 1 | SEC ↗ |
| Chief Medical Officer | Sale | 20,000 | $700K | Oct 3 | SEC ↗ | |
| Chief Medical Officer | Sale | 15,000 | $450K | Sep 16 | SEC ↗ | |
Hamilton James CFirst filing | Chief Medical Officer | Sale | 15,000 | $375K | Sep 4 | SEC ↗ |
Related companies
ARROWHEAD PHARMACEUTICALS, INC. is in the Healthcare sector.